Friday, July 10, 2026

pharma · Ulcerative Colitis · Diabetes Mellitus, Type 2

Eli Lilly and

Eli Lilly and clinical programs — 15 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Lilly Corporate Center, Indianapolis, Indiana 46285, US HQ
55,860 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Lilly Corporate Center, Indianapolis, Indiana 46285, US
Employees
55,860
Programs
62
Drugs
42
Patents
0
Intelligence · Clinical Programs

Eli Lilly and projects

15 ClinicalTrials.gov programs sponsored by Eli Lilly and.

Eli Lilly and has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Insulin Peglispro

    Eli Lilly and Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. LY3039478

    Eli Lilly and Company

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial
  3. LY3053102

    Eli Lilly and Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. LY3209590 (SC)

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial
  5. LY3484356

    Eli Lilly and Company

    Breast Neoplasms

    phase 1 small molecule active

    1 trial
  6. LY3493269

    Eli Lilly and Company

    Healthy

    phase 1 small molecule terminated

    1 trial
  7. LY3493269 - SC

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial
  8. LY3532226

    Eli Lilly and Company

    Obesity

    phase 1 small molecule completed

    1 trial
  9. LY3537021

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial
  10. LY3819469

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial
  11. LY4006896

    Eli Lilly and Company

    Parkinson Disease

    phase 1 small molecule active

    1 trial
  12. Olaratumab

    Eli Lilly and Company

    Malignancy

    phase 1 mab completed

    1 trial
  13. Olomorasib

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial
  14. Tabalumab

    Eli Lilly and Company

    Multiple Myeloma

    phase 1 mab completed

    1 trial
  15. Tirzepatide

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Eli Lilly and have?

15 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.